Performance Updates

Want to track the performance of this manager?

Click the button below to sign up to receive monthly performance updates by email.

Track Manager
Invest Today

Want more information on investing with this manager?

If you are interested in investing in one of Todd Hagopian's funds. Click the link below to get started.

Invest Today

Todd Hagopian

Business Unit Manager - B2B (Former Financial Advisor & Bank Manager)

Investment Strategy

I set up "Valuation Zones", which can consist of P/E, PEG, P/S, or even Price/Book, depending on the sector/situation which I am evaluating.  Depending on the industry, I set loose valuation zones at certain levels, running dozens of companies through a set of filters.  Companies which qualify under these loose valuation zones, I add them to my watch list.  After looking at the broader list, I tighten the valuation zones so that only the stocks that represent a significant discount to fair value emerge.  These are the stocks that I invest in. 

My investing philosophy is to make every dollar work as hard as possible, every minute of the day, based on the underlying belief is that there is always something available to purchase at a discount.  For that reason, I do not try to wait for the perfect moment to buy or sell, but rather frequently evaluates my holdings for opportunities to lock in profits as stocks gain (exiting their "valuation zone"), and reinvest those dollars into stocks within the sector which have fallen into these designated "valuation zones" at any given time.  

Frequent rebalancing is key to the strategy.  As a stock falls into a P/E valuation zone, it will be purchased, and as it surges up 15%, emerging from a valuation zone, it may be sold so that the money can be invested into another stock which has dipped into a P/E valuation zone.  As the second stock surges, and the first falls back to earth, I will rebalance again.The resulting fund's goal is to allow the given fund to attack specific sectors with a much lower risk profile, while trying to lock in greater gains by frequently re-balancing on based on where these stocks are trading, with respect to these valuation zones. 




Funds
(HIBEV) Hagopian Institute BioMed Extreme Value
MODEL INCEPTION (03/05/2011) AVG. ANNUAL RETURN S&P TOTAL RETURN Actions
7+ YRS 22.42% 13.41% View Fund Stats Track Fund
RETURN PERIOD (As Of: 08/31/2018) AVG. ANNUAL RETURN S&P TOTAL RETURN ACHIEVEMENTS
5 YRS 15.62% 16.37% Beat the 50th percentile of mutual funds over 5 years.  
3 YRS 0.57% 11.16% Fund has a 3 year track record.  
1 YR -4.81% 15.43% Fund has a 1 year track record.  
Show Fund Strategy
Click Here to View More Information About This Fund.
(HIDEV) Hagopian Institute Defense Extreme Value
MODEL INCEPTION (03/07/2011) AVG. ANNUAL RETURN S&P TOTAL RETURN Actions
7+ YRS 16.75% 13.42% View Fund Stats Track Fund
RETURN PERIOD (As Of: 08/31/2018) AVG. ANNUAL RETURN S&P TOTAL RETURN ACHIEVEMENTS
5 YRS 19.91% 16.37% Beat the 75th percentile of mutual funds over 5 years.  
3 YRS 21.90% 11.16% Beat the 75th percentile of mutual funds over 3 years.  
1 YR 22.06% 15.43% Beat the 50th percentile of mutual funds over 1 year.  
Show Fund Strategy
Click Here to View More Information About This Fund.
Achievements
  • HIDEV Beat the 75th percentile of mutual funds over 5 years.
    Aug 31, 2018
  • HIDEV Beat the 75th percentile of mutual funds over 3 years.
    Aug 31, 2018
  • HIDEV Beat the 50th percentile of mutual funds over 1 year.
    Aug 31, 2018
Articles

Hagopian Institute BioMed Extreme Value

HIBEV | Price History
HIBEV | Fund Positions by Styles
Color Name Allocation Today
Unclassified Market Cap : Unclassified Style 51.22% -1.63%
Mid Cap : Blend 16.45% -2.51%
Large Cap : Growth 9.54% -2.10%
Mid Cap : Growth 8.96% -0.31%
Micro Cap : Blend 7.05% -2.59%
Micro Cap : Growth 6.78% 3.00%
HIBEV | Fund Information

The information below pertains to model data only.

Fund Manager: Total Model Net Assets:
Todd Hagopian $4,607,387.16
Inception: Ticker Symbol: # of Securities:
March 05, 2011 HIBEV 12
Description:

HIBEV is a Biotech/Pharma Extreme Value fund, which looks for investments within the BioTech/Pharma industry which have (or are on the cusp of) positive earnings, with strong growth prospects, which have dipped into attractive valuation zones.

The fund's long-term objective is to deliver a large alpha return, while strictly controlling the beta.  By focusing on stocks with relatively low P/E ratios, plenty of room between trading price and target price, and stocks which have fallen from their highs, the fund delivers a low-risk/high-return value proposition to investors, even inside a typically-volatile sector, like The Biotech Industry.

HIBEV | Turnover
Last Month 17.6%
Last 3 Months 40.39%
Last 6 Months 91.81%
Last 12 Months 255.66%
HIBEV | 5 Most and Least Profitable
5 MOST PROFITABLE 5 LEAST PROFITABLE
Position Symbol Gains
1 ANIK $709,907.60
2 JAZZ $658,292.46
3 ALXN $643,853.33
4 PTLA $320,084.98
5 ARNA $310,050.01
Position Symbol Gains
1 ZYNE -$451,720.19
2 TSRO -$329,387.08
3 CLVS -$316,017.83
4 INSY -$182,972.10
5 ICPT -$163,390.36
HIBEV | Skill Metrics
All Positions
Winning % 58.75%
Avg. Gain/Loss Ratio 1.54
HIBEV | Fund Positions by Sectors and Industries
Color Name Allocation Today
Health Care 88.87% -1.59%
Other 11.15% 0.72%
HIBEV | Recent Returns vs Major Indexes
Beating Today MTD QTD YTD
HIBEV -0.00% -4.52% -0.36% -3.18%
S&P 500 -0.04% 0.97% 0.00% 0.00%
NASDAQ -0.51% 0.00% 0.00% 0.00%
HIBEV | Recent Returns
Period Returns S&P 500 Returns Returns VS S&P 500
Last 7 Days 0.35% 0.86% -0.51%
Last 30 Days 2.94% 2.54% 0.40%
Last 3 Months -4.59% 6.84% -11.43%
Last 6 Months 4.59% 14.28% -9.69%
Last 12 Months -9.96% 19.44% -29.40%
Last 2 Years 13.68% 40.95% -27.27%
Last 3 Years 2.02% 60.43% -58.41%
Last 5 Years 86.29% 89.96% -3.67%
Since Inception 360.74% 162.08% 198.66%
(Annualized) 22.43% 13.62% 8.81%
Data as of: 09/21/2018
HIBEV | Alpha/Beta VS. S&P 500
Alpha 0%
Beta 0
R-Squared 0
HIBEV | 5 Best and Worst Returns
5 BEST 5 WORST
Position Symbol Inception Return
1 ALXN 102.16%
2 OMER 32.41%
3 CLLS 12.77%
4 FLXN 10.50%
5 XXII 8.36%
Position Symbol Inception Return
1 CLVS -30.61%
2 TSRO -24.12%
3 ADMS -13.38%
4 RDUS -7.34%
5 INCY -5.96%